Cargando…

Body weight variability and the risk of cardiovascular outcomes in patients with nonalcoholic fatty liver disease

We investigated the association between body weight variability and the risks of cardiovascular disease and mortality in patients with nonalcoholic fatty liver disease (NAFLD) using large-scale, nationwide cohort data. We included 726,736 individuals with NAFLD who underwent a health examination bet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Mi Na, Han, Kyungdo, Yoo, Juhwan, Ha, Yeonjung, Chon, Young Eun, Lee, Ju Ho, Simon, Tracey G., Chan, Andrew T., Hwang, Seong Gyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080815/ https://www.ncbi.nlm.nih.gov/pubmed/33911167 http://dx.doi.org/10.1038/s41598-021-88733-3

Ejemplares similares

The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: A Population-Based Study
por: Ha, Yeonjung, et al.
Publicado: (2017)

Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarate
por: Ha, Yeonjung, et al.
Publicado: (2020)

Validation of the Liver Disease Quality of Life Instrument 1.0 in Patients with Chronic Hepatitis B: A Prospective Study
por: Ha, Yeonjung, et al.
Publicado: (2019)

Body weight gain rather than body weight variability is associated with increased risk of nonalcoholic fatty liver disease
por: Cho, Eun Ju, et al.
Publicado: (2021)

Decrease in waist-to-hip ratio reduced the development of chronic kidney disease in non-obese non-alcoholic fatty liver disease
por: Chon, Young Eun, et al.
Publicado: (2020)

Increased Risk of Nonalcoholic Fatty Liver Disease in Individuals with High Weight Variability
por: Jung, Inha, et al.
Publicado: (2021)

Cirrhosis, Age, and Liver Stiffness-Based Models Predict Hepatocellular Carcinoma in Asian Patients with Chronic Hepatitis B
por: Lim, Jihye, et al.
Publicado: (2021)

Combined Effects of Chronic Kidney Disease and Nonalcoholic Fatty Liver Disease on the Risk of Cardiovascular Disease in Patients with Diabetes
por: Chung, Goh-Eun, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease is associated with the development of obstructive sleep apnea
por: Chung, Goh Eun, et al.
Publicado: (2021)

Changes in liver stiffness values assessed using transient elastography in chronic hepatitis B patients treated with tenofovir disoproxil fumarate: a prospective observational study
por: Cho, Heejin, et al.
Publicado: (2023)

Interaction between the PNPLA3 Gene and Nutritional Factors on NAFLD Development: The Korean Genome and Epidemiology Study
por: Oh, Sooyeon, et al.
Publicado: (2022)

Variability in body weight precedes diagnosis in dementia: A nationwide cohort study
por: Ha, Jane, et al.
Publicado: (2020)

Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function
por: Ha, Yeonjung, et al.
Publicado: (2018)

The effect of metabolic dysfunction-associated fatty liver disease and diabetic kidney disease on the risk of hospitalization of heart failure in type 2 diabetes: a retrospective cohort study
por: Lee, Seung Eun, et al.
Publicado: (2023)

Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study
por: Kim, Beom Kyung, et al.
Publicado: (2022)

Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment
por: Chon, Young Eun, et al.
Publicado: (2022)

The transcontinental variability of nonalcoholic fatty liver disease
por: Oliveira, Claudia P., et al.
Publicado: (2020)

Factors Affecting High Body Weight Variability
por: Han, Kyungdo, et al.
Publicado: (2023)

Prediction of Cardiovascular Risk Using Nonalcoholic Fatty Liver Disease Scoring Systems
por: Kweon, Ye-Na, et al.
Publicado: (2021)

Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
por: Lee, Yun Bin, et al.
Publicado: (2019)

Association between organochlorine pesticides and nonalcoholic fatty liver disease in the National Health and Nutrition Examination Survey 2003–2004
por: Sang, Hyunji, et al.
Publicado: (2022)

The Impact of Weight Changes on Nonalcoholic Fatty Liver Disease in Adult Men with Normal Weight
por: Cho, Ji-Young, et al.
Publicado: (2014)

Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease
por: Lee, Hye Won, et al.
Publicado: (2016)

Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease
por: Arvind, Ashwini, et al.
Publicado: (2021)

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
por: Kim, Yuna, et al.
Publicado: (2022)

Importance of Variables in Nonalcoholic Fatty Liver Disease Patients
por: Garg, Vivek Kumar, et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease Is a Precursor of New-Onset Metabolic Syndrome in Metabolically Healthy Young Adults
por: Yoo, Jeong-Ju, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes
por: You, Sang Youn, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease and cardiovascular disease phenotypes
por: Bisaccia, Giandomenico, et al.
Publicado: (2020)

The Effect of Weight Reduction on Ultrasonographic Findings of Nonalcoholic Fatty Liver
por: Tahaei, SA, et al.
Publicado: (2010)

The Effect of Weight Loss on Pediatric Nonalcoholic Fatty Liver Disease
por: St-Jules, David E., et al.
Publicado: (2013)

Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease
por: Kumar, Mavidi Sunil, et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter
por: Chiriac, Stefan, et al.
Publicado: (2021)

The utility of ezetimibe therapy in nonalcoholic fatty liver disease
por: Jun, Baek Gyu, et al.
Publicado: (2019)

Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
por: Lee, Ji-Yeon, et al.
Publicado: (2022)

Role of Hyperinsulinemia and Glucose Intolerance in the Pathogenesis of Nonalcoholic Fatty Liver in Patients with Normal Body Weight
por: Lee, Joon Hyoek, et al.
Publicado: (1998)

Recent research trends and updates on nonalcoholic fatty liver disease
por: Yoo, Jeong-Ju, et al.
Publicado: (2019)

How Much Weight Loss is Effective on Nonalcoholic Fatty Liver Disease?
por: Ghaemi, Alireza, et al.
Publicado: (2013)

Impairment of Quality of Life and Mental Health Status in Adult-Onset Atopic Dermatitis
por: Yoo, Juhwan, et al.
Publicado: (2022)

Fatty Liver Index for Predicting Nonalcoholic Fatty Liver Disease in an Asymptomatic Korean Population
por: Cho, Eun-Ju, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nb52fbt84d4lretpn8t6h37qum